Understanding Coagulation and Inflammation in Burns
NCT03077269 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2026-02-13
Summary
The purpose of this study is to understand what happens to platelets and blood clotting factors in burn patients over time. This study will also examine the role of microparticles (MPs), nanoparticles (NPs), and micro RNA in burns. The investigators will be looking at small particles of cells that are released into the blood. These particles have been found to be important in a variety of different diseases. The investigators believe that MPs, NPs, and micro RNA may play a role in development of inflammation, and infections in burn patients. Thus, hopefully, this study will help understand how to minimize transfusions and bleeding in burn patients as well as how to reduce inflammation and infections in burn patients.
Conditions
- Burns
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-01
- Primary Completion
- 2025-05-19
- Completion
- 2025-05-19
Countries
- United States
Study Locations
More Related Trials
-
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
NCT04252651 ·Status: UNKNOWN
-
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
NCT02673229 ·Status: TERMINATED ·Phase: PHASE4
-
Microbiome Changes in Severe Burns
NCT03130868 ·Status: COMPLETED
-
Albumin Use in Burn Patients
NCT00609414 ·Status: COMPLETED
-
The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites
NCT03937765 ·Status: TERMINATED ·Phase: NA
-
Study of the Cutaneous Reinnervation After Burn
NCT02356354 ·Status: TERMINATED ·Phase: NA
-
Study of Silicone Material Inserts To Treat Burn Scars
NCT03159182 ·Status: WITHDRAWN ·Phase: NA
-
Adult Stem Cell Response to Burn Injury
NCT00609661 ·Status: WITHDRAWN
-
Large Burn Outcome Study
NCT00731887 ·Status: WITHDRAWN
-
SN514-066b Enzyme in Deep Partial Thickness Burns
NCT06628037 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Testing an Innovative Biomarker: Expression of HIF-1α and Its Isoforms in the Blood and Skin Tissue of Major Burns
NCT02870439 ·Status: UNKNOWN ·Phase: NA
-
Single-Stage Integra Reconstruction in Burns
NCT03077087 ·Status: TERMINATED ·Phase: NA
-
HLA Sensitization in Severely Burned Patients
NCT02537821 ·Status: UNKNOWN
-
Investigation of the Clinical Performance of Biatain Fiber Ag on Burns
NCT05824026 ·Status: COMPLETED ·Phase: NA
-
Keratinocyte Growth Factor and Cytokines in Burns.
NCT01302223 ·Status: COMPLETED
-
Biofilm Infection in Adults and Children Burn Injury
NCT03248154 ·Status: WITHDRAWN ·Phase: NA
-
A Trial of Restrictive Versus Traditional Blood Transfusion Practices in Burn Patients
NCT01079247 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study of a Novel Phototherapy System for the Management of Acute Burns
NCT04011306 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns
NCT01636362 ·Status: COMPLETED ·Phase: NA
-
Antimicrobial Resistance of Bacteria in Burn Patients
NCT00794742 ·Status: COMPLETED
-
Treatment of Patients With Skin Burns Using Keratinocytes and Skin Fibroblasts
NCT04485962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites
NCT03334656 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds
NCT00161759 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1
NCT07249762 ·Status: NOT_YET_RECRUITING
-
A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns
NCT06814717 ·Status: RECRUITING ·Phase: PHASE2